Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins

Journal of Molecular Biology

Volumn 304, Issue 2, 2000, Pages 177-188

  Li, Yili ^a   Li, Hongmin ^a   Martin, Roland ^b   Mariuzza, Roy A ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

HLA DR2; MHC class II; Multiple sclerosis; Myelin basic protein; X ray crystallography

Indexed keywords

HLA DR2 ANTIGEN; ISOLEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; PHENYLALANINE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; VALINE;

ARTICLE; HAPLOTYPE; HLA SYSTEM; HUMAN; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; T LYMPHOCYTE; X RAY CRYSTALLOGRAPHY;

EID: 0034711376     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4198     Document Type: Article

References (45)

1. Encephalitogenic potential of myelin basic protein peptide (83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
2. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
3. Crystallography and NMR system: A new software suite for macromolecular structure determination
4. The CCP4 suite: Programs for protein crystallography
5. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB*0401) complexed with a peptide from human collagen II
6. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles
7. A full genome search in multiple sclerosis
8. Principles of protein stability derived from protein engineering experiments
9. Empty and peptide-loaded class II MHC proteins produced by expression in E. coli and refolding in vitro
10. Structures of an MHC class II molecule with covalently bound single peptides
11. Crystal structure of I-A(k) in complex with a dominant epitope of lysozyme
12. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
13. Promiscuous and allele-specific anchors in HLA-DR-binding peptides
14. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations
15. The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families
16. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals
17. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex
18. PROCHECK: A program to check the stereochemical quality of protein structures
19. Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction
20. The three-dimensional structure of peptide-MHC complexes
21. A humanized model for multiple sclerosis utilizing HLA-DR2 and a human T cell receptor
22. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
23. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: Implications for the structural basis of the specificity of peptide binding
24. AMoRe: An automated package for molecular replacement
25. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
26. Genetics of demyelinating diseases
27. On the interaction of promiscuous antigenic peptides with different DR alleles
28. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis
29. Processing X-ray diffraction data collected in oscillation mode
30. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basis protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors
31. The crystal structure of a T cell receptor in complex with peptide and MHC class II
32. TURBO-FRODO
33. Crystal structures of two I-A(d)-peptide complexes reveal that high affinity can be achieved without large anchor residues
34. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop
35. A malarial T-cell epitope recognized in association with most mouse and human MHC class II molecules
36. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein
37. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules
38. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
39. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide
40. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
41. Refolding of human class II major histocompatibility complex molecules isolated from Escherichia coli
42. Binding of myelin basic protein peptides to human histocompatibility antigen class II molecules and their recognition by T cells from multiple sclerosis patients
43. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: Peptide binding, immunodominance and effector functions of T cells
44. Ligand motifs of HLA-DRB5*0101* DRB1*1501 molecules delineated from self-peptides
45. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones